Metastatic bladder cancer immunotherapy outcomes better with antihistamines
Renal + Urology News highlights UC-led research
Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using antihistamines in patients receiving second-line immunotherapy (IO) for bladder cancer may improve outcomes.
The research, published in the journal Urologic Oncology, focused on metastatic urothelial carcinoma (mUC), cancer that begins in the urothelial cells, which line the urethra, bladder, ureters and some other organs. Martini, University of Cincinnati Cancer Center physician-researcher and assistant professor in the Department of Urology in UC's College of Medicine, served as corresponding author of the study.
Using data from two clinical trials, the researchers identified 896 patients who were treated with second-line IO drug atezolizumab. Out of those patients, 155 patients received concomitant antihistamines and 741 did not.
Antihistamine users had 41% lower risk for all-cause mortality, 42% lower risk for cancer death and 30% lower risk of cancer progression compared to patients that did not receive antihistamines.
“Our results show a positive association between the use of antihistamines and oncologic outcome in patients with mUC treated with IO,” Martini and colleagues concluded.
Read the Renal + Urology News story.
Featured photo at top of urothelial carcinoma cells stained purple. Photo/OGPhoto/iStock.
Related Stories
UC's art collection on display at the Contemporary Arts Center
January 5, 2026
University of Cincinnati leaders joined WVXU's Cincinnati Edition to talk about the university’s 200-year-old art collection, a new exhibition at the Contemporary Arts Center and the release of a companion book exploring the collection’s role in education and public engagement.
UC faculty and staff among Rising Star leadership honorees
January 5, 2026
Two UC faculty and staff members are among this year's Rising Star leadership program sponsored by YWCA Greater Cincinnati. Kelli Beecher, assistant professor in the UC College of Nursing, and Brittany Bibb, assistant director of programs and operations in the UC Division of Student Affairs, are among the emerging leaders of 2026. They were featured in the publication Movers & Makers.
What's behind the mysterious rise of migraines?
January 5, 2026
Weather patterns such as extreme heat and storm conditions have been linked to migraine attacks, and research shows those environmental conditions are becoming more common. As National Geographic recently reported, one of the leading theories behind this mysterious rise is that climate change may be playing a role.